Plasma thrombospondin levels in patients with colorectal carcinoma

Cancer

Volumn 82, Issue 4, 1998, Pages 632-638

  Yamashita, Yuichi ^a   Kurohiji, Toshihiko ^b   Tuszynski, George P ^c   Sakai, Toshimi ^a   Shirakusa, Takayuki ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Koga Hospital   (Japan)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Colorectal carcinoma; Dukes staging; Thrombospondin; Venous invasion

Indexed keywords

THROMBOSPONDIN;

ARTICLE; BASEMENT MEMBRANE; BLOOD SAMPLING; CANCER INVASION; CANCER STAGING; COLORECTAL CARCINOMA; DRUG BLOOD LEVEL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; THROMBOSPONDINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032519607     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980215)82:4<632::AID-CNCR3>3.0.CO;2-N     Document Type: Article

References (41)

1. Baenziger NL, Brodie GN, Majerus PW. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci USA 1971; 68:240-3.
2. Baenziger NL, Brodie GN, Majerus PW. Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem 1972; 247:2723-31.
3. Lawler JW, Slayter HS, Coligan JE. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 1978; 253:8609-16.
4. Tuszynski GP, Srivastava S, Switalska HI, Holt JC, Cierniewski CS, Niewiarowski S. The interaction of human platelet thrombospondin with fibrinogen: thrombospondin purification and specificity of interaction. J Biol Chem 1985; 260: 12240-5.
5. Mosher DF, Doyle MF, Jaffe FA. Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Cell Biol 1982; 93:343-8.
6. McPherson J, Sage H, Bornstein P. Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture: apparent identity with platelet thrombospondin. J Biol Chem 1981; 256:11330-6.
7. Raugi GJ, Mumby SM, Abbott-Brown D, Bornstein P. Thrombospondin: synthesis and secretion by cells in culture. J Cell Biol 1982; 95:351-4.
8. Jaffe EA, Ruggiero JT, Leung LLK, Doyle MJ, McKeown-Longo PJ, Mosher DF. Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci USA 1983; 80:998-1002.
9. Jaffe EA, Ruggiero JT, Falcone DJ. Monocytes and macrophages synthesize and secrete thrombospondin. Blood 1985; 65:79-84.
10. McLaren KM. Immunohistochemical localization of thrombospondin in human megakaryocytes and platelets. J Clin Pathol 1983; 36:197-9.
11. Riser BL, Varani J, O'Rourke K, Dixit VM. Thrombospondin binding by human squamous carcinoma and melanoma cells: relationship to biological activity. Exp Cell Res 1988; 174:319-29.
12. Varani J, Riser BL, Hughes LA, Carey TE, Fligiel SEG, Dixit VM. Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells. Clin Exp Metastasis 1989; 7:265-76.
13. Zabrenetzky V, Harris CC, Steeg PS, Roberts DD. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 1994; 59: 191-5.
14. Wight TN, Raugi GJ, Mumby SM, Bornstein P. Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem 1985; 33:295-302.
15. Tuszynski GP. Thrombospondin promotes cell-substratum adhesion. Science 1987; 236:1570-3.
16. Hosokawa T, Muraisi A, Rothman VL, Papale M, Tuszynski GP. The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma. Oncol Res 1993; 5:5183-9.
17. Tuszynski GP, Smith M, Rothman VL, Capuzzi MD, Joseph RR, Katz J. Thrombospondin levels in patients with malignancy. Thromb Haemost 1992; 67:607-11.
18. Nathan FE, Hernandez E, Dunton CJ, Treat J, Switalska HI, Joseph RR, et al. Plasma thrombospondin levels in patients with gynecologic malignancies. Cancer 1994; 73:2853-8.
19. Grinnel RS. The lymphatic and venous spread of carcinoma of the rectum. Ann Surg 1942; 116:200-16.
20. Carrol SE. The prognostic significance of gross venous invasion in carcinoma of the rectum. Can J Surg 1963; 6:281-8.
21. Khankhanian N, Mavligit GM, Russell WO, Schimek M. Prognostic significance of vascular invasion in colorectal cancer of Dukes' B class. Cancer 1977; 39:1195-200.
22. Talbot IC, Ritchie S. The clinical significance of invasion of veins by rectal cancer. Br J Surg 1980; 67:439-42.
23. Minsky BD, Mies C. The clinical significance of vascular invasion in colorectal cancer. Dis Colon Rectum 1989; 32:794-803.
24. Krasna MJ, Flancbaum L, Cody RP, Shneibaum S, Ari GB. Vascular and neural invasion in colorectal carcinoma: incidence and prognostic significance. Cancer 1988; 61:1018-23.
25. Kam-Kei L, Munetomo E, Kiyoshi I. Venous permeation of colorectal carcinoma. Jpn J Surg 1980; 10:288-9.
26. Tuszynski GP, Switalska HI, Knudsen K. Methods of studying platelet-secreted proteins and the platelet cytoskeleton. In: Smith B, Colman R, editors. Modern methods in pharmacology. Volume 4. New York: Alan R. Liss, Inc., 1987:267-86.
27. Lui KK, Enjoji M, Inokuchi K. Venous permeation of colorectal carcinoma. Jpn J Surg 1980; 10:284-9.
28. Turnbull RB, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967; 166:420-7.
29. Gartner TK, Gerrard JM, White JG, Williams DC. Fibrinogen is the receptor for the endogenous lection of human platelets. Nature 1981; 289:688-90.
30. Lahav J, Schwartz MA, Hynes RO. Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: interaction of thrombospondin with fibronectin and collagen. Cell 1982; 31:253-62.
31. Galvin NJ, Vance PM, Dixit VM, Fink B, Frazier WA. Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. J Cell Biol 1987; 104: 1413-22.
32. Dawes J, Pratt DA, Dewar MS, Preston FE. Do extra-platelet sources contribute to the plasma level of thrombospondin? Thromb Haemost 1988;59:276-81.
33. Switalska HI, Niewiarowski S, Tuszynski GP, Rucinski B, Schmaier AH, Morinelli TA, et al. Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and β-thromboglobulin antigen secretion and clearance from the circulation. J Lab Clin Med 1985; 106:690-700.
34. Nakamura Y. Localization of thrombospondin in hepatocellular carcinoma [in Japanese]. J Kurume Med Assoc 1994; 57: 740-8.
35. Wong SY, Puradie AT, Han P. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. Am J Pathol 1992; 140:1473-82.
36. Gasic GJ, Gasic TB, Stewart CC. Antimetastasic effects associated with platelet reduction. Proc Natl Acad Sci USA 1968; 61:46-52.
37. Stringfellow DA, Fitzpatrick FA. Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells. Nature 1979; 282:76-8.
38. Pearlstein E, Ambrogio C, Karpatkin S. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cell into mice. Cancer Res 1984; 44:3884-7.
39. Tuszynski GP, Rothman VL, Switalska HI, Smith MD, Katz J, Joseph RR. Thrombospondin mediates tumor cell metastasis [abstract]. Thromb Haemost 1989; 62:22.
40. Tuszynski GP, Gasic TB, Rothman VL, Knudsen KA, Gasic GJ. Thrombospondin, a potentiator of tumor cell metastasis. Cancer 1987; 47:4130-3.
41. Dawes J, Clemetson KJ, Gogstad GO. A radioimmunoassay for thrombospondin used in a comparative study of thrombospondin, beta-thrombospondin and platelet factor 4 in healthy volunteers. Thromb Res 1983; 29:569-82.